Search Results - "Nardo, L. G."

Refine Results
  1. 1

    Anti-Müllerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF by Yates, A.P., Rustamov, O., Roberts, S.A., Lim, H.Y.N., Pemberton, P.W., Smith, A., Nardo, L.G.

    Published in Human reproduction (Oxford) (01-09-2011)
    “…BACKGROUND Anti-Müllerian hormone (AMH) is increasingly used to quantify ovarian reserve, but it has not yet realized its full clinical potential in assisted…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Anti-Müllerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability by Rustamov, Oybek, Smith, Alexander, Roberts, Stephen A., Yates, Allen P., Fitzgerald, Cheryl, Krishnan, Monica, Nardo, Luciano G., Pemberton, Philip W.

    Published in Human reproduction (Oxford) (01-10-2012)
    “…STUDY QUESTION What is the variability of anti-Müllerian hormone (AMH) concentration in repeat samples from the same individual when using the Gen II assay and…”
    Get full text
    Journal Article
  4. 4

    The risk of monozygotic twins after assisted reproductive technology: a systematic review and meta-analysis by Vitthala, S., Gelbaya, T.A., Brison, D.R., Fitzgerald, C.T., Nardo, L.G.

    Published in Human reproduction update (01-01-2009)
    “…BACKGROUND It is estimated that there is at least a 2-fold rise in the incidence of monozygotic twinning after assisted reproductive technology compared with…”
    Get full text
    Journal Article
  5. 5

    Metformin therapy in the management of polycystic ovary syndrome : endocrine, metabolic and reproductive effects by NARDO, L. G, RAI, R

    Published in Gynecological endocrinology (01-10-2001)
    “…Polycystic ovary syndrome (PCOS) is a convergence of multisystem endocrine derangements. Impairment in insulin metabolism is a prominent feature of the…”
    Get full text
    Journal Article
  6. 6

    Implantation, clinical pregnancy and miscarriage rates after introduction of ultrasound-guided embryo transfer by Ali, C Rubina, Khashan, AS, Horne, G, Fitzgerald, CT, Nardo, LG

    Published in Reproductive biomedicine online (2008)
    “…Abstract The purpose of this study was to compare the reproductive outcome of ultrasound-guided (USG) embryo transfers versus clinical touch embryo transfers…”
    Get full text
    Journal Article
  7. 7

    Management of anovulatory infertility associated with polycystic ovary syndrome: tamoxifen citrate an effective alternative compound to clomiphene citrate by Nardo, LG

    Published in Gynecological endocrinology (01-11-2004)
    “…Clomiphene citrate (CC) is widely used as first-line treatment for ovulation induction in anovulatory women with polycystic ovary syndrome (PCOS). Tamoxifen…”
    Get full text
    Journal Article
  8. 8

    Pinopode expression during human implantation by Nardo, L.G., Sabatini, L., Rai, R., Nardo, F.

    “…Implantation failure is considered the major impediment to successful in vitro fertilization pregnancy rate. Despite recent advances in reproductive medicine,…”
    Get full text
    Journal Article
  9. 9

    Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis by Gelbaya, T.A., Kyrgiou, M., Li, T.C., Stern, C., Nardo, L.G.

    Published in Human reproduction update (01-07-2007)
    “…Despite recent advances in ovarian stimulation regimens and laboratory techniques, the pregnancy rate of assisted reproduction remains relatively low. New…”
    Get full text
    Journal Article
  10. 10

    Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee by Nardo, L.G., Bosch, E., Lambalk, C.B., Gelbaya, T.A.

    Published in Human fertility (Cambridge, England) (01-09-2013)
    “…Abstract Before planning an assisted conception treatment cycle, a thorough assessment of the woman's hormone profile and ovarian reserve is essential to aid…”
    Get full text
    Journal Article
  11. 11

    Altered glycosylation in peri-implantation phase endometrium in women with stages III and IV endometriosis by Miller, D.L., Jones, C.J.P., Aplin, J.D., Nardo, L.G.

    Published in Human reproduction (Oxford) (01-02-2010)
    “…BACKGROUND Endometriosis is a common cause of infertility and pelvic pain. Lectin histochemistry has shown that glycan expression is a sensitive marker of…”
    Get full text
    Journal Article
  12. 12

    Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization by Nardo, L. G., Ray, D. W., Laing, I., Williams, C., Mcvey, R. J., Seif, M. W.

    Published in Gynecological endocrinology (01-10-2005)
    “…Abstarct The authors report a case of Leydig cell tumor in a 46-year-old woman who first presented with severe clinical hyperandrogenism and associated complex…”
    Get full text
    Journal Article
  13. 13

    Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications by Nardo, L G, Patchava, S, Laing, I

    Published in Panminerva medica (01-12-2008)
    “…Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age (5-10% prevalence) and the most common cause of anovulatory…”
    Get more information
    Journal Article
  14. 14

    Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction by Manna, Claudio, Rahman, A, Sbracia, M, Pappalardo, S, Mohamed, EI, Linder, R, Nardo, LG

    Published in Gynecological endocrinology (01-04-2005)
    “…Gonadotrophin-releasing hormone analogues (GnRH-a) are used widely in controlled ovarian stimulation (COS) cycles for assisted reproduction. At present, there…”
    Get full text
    Journal Article
  15. 15

    Concentrations of insulin-like growth factor (IGF)-I and IGF binding protein-3 in the follicular fluid of women undergoing ovarian hyperstimulation with different gonadotropin preparations by NARDO, L. G, BELLANCA, S. A, BURRELLO, N, LONGO, G, D'AGATA, R, NARDO, F, CALOGERO, A. E

    Published in Gynecological endocrinology (01-12-2001)
    “…Insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) have an important regulatory role in follicular development and oocyte maturation. The…”
    Get full text
    Journal Article
  16. 16

    Anti-Müllerian Hormone-Tailored Stimulation Protocols Improve Outcomes While Reducing Adverse Effects and Costs of IVF by Yates, A. P, Rustamov, O, Roberts, S. A, Lim, H. Y. N, Pemberton, P. W, Smith, A, Nardo, L. G

    Published in Obstetrical & gynecological survey (01-12-2011)
    “…Anti-Müllerian hormone (AMH) is a sensitive marker of ovarian reserve. Some investigators have reported that AMH is the most sensitive predictor of both over-…”
    Get full text
    Journal Article
  17. 17

    Customised fetal growth chart: A systematic review by Gelbaya, T. A., Nardo, L. G.

    Published in Journal of obstetrics and gynaecology (01-07-2005)
    “…Summary Customised fetal growth chart is used to individualise fetal weight for gestational age by adjusting for physiological variables known to affect birth…”
    Get full text
    Journal Article
  18. 18

    Stimulated intrauterine insemination (SIUI) and donor insemination (DI) as first line management for a selected subfertile population: the Manchester experience by Vitthala, S., Gelbaya, T. A., Hunter, H., Roberts, S. A., Nardo, L. G.

    “…Purpose The objective of our study is to investigate the optimum number of stimulated intrauterine insemination (SIUI) or donor insemination (DI) cycles that…”
    Get full text
    Journal Article
  19. 19

    Vascular endothelial growth factor expression in the endometrium during the menstrual cycle, implantation window and early pregnancy by Nardo, Luciano G

    Published in Current opinion in obstetrics & gynecology (01-08-2005)
    “…The review aims to summarize recent data about vascular endothelial growth factor and its implications in the normal endometrium during the menstrual cycle,…”
    Get full text
    Journal Article
  20. 20

    High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage by Nardo, Luciano G, Rai, Raj, Backos, May, El-Gaddal, Safaa, Regan, Lesley

    Published in Fertility and sterility (01-02-2002)
    “…To investigate the relationship between Day 8 serum luteinizing hormone (LH) and testosterone (T) concentrations, and body mass index (BMI) with pregnancy…”
    Get more information
    Journal Article